A Study on Efficacy, Safety and Immunogenicity of 9MW0311 in Postmenopausal Women With Osteoporosis

Clinical trial NCT06804590 · COMPLETED

Trial details

NCT number: NCT06804590
Sponsor: Mabwell (Shanghai) Bioscience Co., Ltd.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Postmenopausal Women Osteoporosis

Start date: 2024-11-16
Primary completion: 2026-04-24
Enrollment: 280

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.